{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:05:56Z","timestamp":1783969556602,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"French Government \/ University of Bordeaux"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Digit Imaging. Inform. med."],"DOI":"10.1007\/s10278-026-02118-4","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:36:29Z","timestamp":1783967789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Estimating Metastatic Disease Heterogeneity Using Radiomics-based Lesion Clustering and Heterogeneity Index - Application in Lung Adenocarcinoma Patients and Correlations With Patient Outcomes"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0561-2052","authenticated-orcid":false,"given":"Letuan","family":"Phan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lou Andrea","family":"Sitruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Masson\u2013Grehaigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Lafon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bonhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Palussi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Lassau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Italiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Cousin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Cromb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"2118_CR1","doi-asserted-by":"publisher","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511(7511):543-550. https:\/\/doi.org\/10.1038\/nature13385","DOI":"10.1038\/nature13385"},{"key":"2118_CR2","doi-asserted-by":"publisher","unstructured":"McGranahan N, Swanton C. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell. 2017;168(4):613-628. https:\/\/doi.org\/10.1016\/j.cell.2017.01.018","DOI":"10.1016\/j.cell.2017.01.018"},{"key":"2118_CR3","doi-asserted-by":"publisher","unstructured":"MacDonald WJ, Purcell C, Pinho-Schwermann M, Stubbs NM, Srinivasan PR, El-Deiry WS. Heterogeneity in Cancer. Cancers. 2025;17(3):441. https:\/\/doi.org\/10.3390\/cancers17030441","DOI":"10.3390\/cancers17030441"},{"key":"2118_CR4","doi-asserted-by":"publisher","unstructured":"Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong KK. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014;14(8):535-546. https:\/\/doi.org\/10.1038\/nrc3775","DOI":"10.1038\/nrc3775"},{"key":"2118_CR5","doi-asserted-by":"publisher","unstructured":"de Sousa VML, Carvalho L. Heterogeneity in Lung Cancer. Pathobiology. 2018;85(1-2):96-107. https:\/\/doi.org\/10.1159\/000487440","DOI":"10.1159\/000487440"},{"key":"2118_CR6","doi-asserted-by":"publisher","unstructured":"Debieuvre D, Molinier O, Falchero L, et al. Lung cancer trends and tumor characteristic changes over 20 years (2000\u20132020): Results of three French consecutive nationwide prospective cohorts\u2019 studies. The Lancet Regional Health - Europe. 2022;22:100492. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100492","DOI":"10.1016\/j.lanepe.2022.100492"},{"key":"2118_CR7","doi-asserted-by":"publisher","unstructured":"Jamal-Hanjani M, Wilson GA, McGranahan N, et al. Tracking the Evolution of Non\u2013Small-Cell Lung Cancer. N Engl J Med. 2017;376(22):2109-2121. https:\/\/doi.org\/10.1056\/NEJMoa1616288","DOI":"10.1056\/NEJMoa1616288"},{"key":"2118_CR8","unstructured":"Shannon CE. A Mathematical Theory of Communication."},{"key":"2118_CR9","doi-asserted-by":"publisher","unstructured":"Shen S, Wei Y, Zhang R, et al. Mutant\u2011allele fraction heterogeneity is associated with non\u2011small cell lung cancer patient survival. Oncol Lett. Published online November 15, 2017. https:\/\/doi.org\/10.3892\/ol.2017.7428","DOI":"10.3892\/ol.2017.7428"},{"key":"2118_CR10","doi-asserted-by":"publisher","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2016;278(2):563-577. https:\/\/doi.org\/10.1148\/radiol.2015151169","DOI":"10.1148\/radiol.2015151169"},{"key":"2118_CR11","doi-asserted-by":"publisher","unstructured":"Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749-762. https:\/\/doi.org\/10.1038\/nrclinonc.2017.141","DOI":"10.1038\/nrclinonc.2017.141"},{"key":"2118_CR12","doi-asserted-by":"publisher","unstructured":"Shiri I, Maleki H, Hajianfar G. Next-generation radiogenomics sequencing for prediction of EGFR and KRAS mutation status in NSCLC patients using multimodal imaging and machine learning algorithms. Mol Imaging Biol. 2020;22. https:\/\/doi.org\/10.1007\/s11307-020-01487-8","DOI":"10.1007\/s11307-020-01487-8"},{"key":"2118_CR13","doi-asserted-by":"publisher","unstructured":"Rios Velazquez E, Parmar C, Liu Y. Somatic mutations drive distinct imaging phenotypes in lung cancer. Cancer Res. 2017;77. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0122","DOI":"10.1158\/0008-5472.CAN-17-0122"},{"key":"2118_CR14","doi-asserted-by":"publisher","unstructured":"Kim S, Lim JH, Kim CH, et al. Deep learning\u2013radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients. Sci Rep. 2024;14(1):922. https:\/\/doi.org\/10.1038\/s41598-024-51630-6","DOI":"10.1038\/s41598-024-51630-6"},{"key":"2118_CR15","doi-asserted-by":"publisher","unstructured":"Fuster-Matanzo A, Pic\u00f3 Peris A, Bellv\u00eds Bataller F, et al. Prediction of oncogenemutation status in non-small cell lung cancer: A systematic review and meta-analysiswith a special focus on artificial-intelligence-based methods. Radiology and Imaging.Preprint posted online May 31, 2024. https:\/\/doi.org\/10.1101\/2024.05.31.24308261","DOI":"10.1101\/2024.05.31.24308261"},{"key":"2118_CR16","doi-asserted-by":"publisher","unstructured":"Chang C, Sun X, Wang G. A machine learning model based on PET\/CT radiomics and clinical characteristics predicts ALK rearrangement status in lung adenocarcinoma. Front Oncol. 2021;11. https:\/\/doi.org\/10.3389\/fonc.2021.603882","DOI":"10.3389\/fonc.2021.603882"},{"key":"2118_CR17","doi-asserted-by":"publisher","unstructured":"Chen W, Lin G, Feng Y, et al. Intratumoral and peritumoral CT radiomics in predicting anaplastic lymphoma kinase mutations and survival in patients with lung adenocarcinoma: a multicenter study. Cancer Imaging. 2025;25(1):35. https:\/\/doi.org\/10.1186\/s40644-025-00856-2","DOI":"10.1186\/s40644-025-00856-2"},{"key":"2118_CR18","doi-asserted-by":"publisher","unstructured":"Sun Z, Hu S, Ge Y, et al. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features. Journal of X-Ray Science and Technology: Clinical Applications of Diagnosis and Therapeutics. 2020;28(3):449-459. https:\/\/doi.org\/10.3233\/XST-200642","DOI":"10.3233\/XST-200642"},{"key":"2118_CR19","doi-asserted-by":"publisher","unstructured":"Lu J, Liu X, Ji X, et al. Predicting PD-L1 status in NSCLC patients using deep learning radiomics based on CT images. Sci Rep. 2025;15(1):12495. https:\/\/doi.org\/10.1038\/s41598-025-91575-y","DOI":"10.1038\/s41598-025-91575-y"},{"key":"2118_CR20","doi-asserted-by":"publisher","unstructured":"Zhang Y, Oikonomou A, Wong A, Haider MA, Khalvati F. Radiomics-based Prognosis Analysis for Non-Small Cell Lung Cancer. Sci Rep. 2017;7(1):46349. https:\/\/doi.org\/10.1038\/srep46349","DOI":"10.1038\/srep46349"},{"key":"2118_CR21","doi-asserted-by":"publisher","unstructured":"Henry T, Sun R, Lerousseau M, et al. Investigation of radiomics based intra-patient inter-tumor heterogeneity and the impact of tumor subsampling strategies. Sci Rep. 2022;12(1):17244. https:\/\/doi.org\/10.1038\/s41598-022-20931-z","DOI":"10.1038\/s41598-022-20931-z"},{"key":"2118_CR22","doi-asserted-by":"publisher","unstructured":"Chang E, Joel MZ, Chang HY, et al. Comparison of radiomic feature aggregationmethods for patients with multiple tumors. Sci Rep. 2021;11(1):9758.  https:\/\/doi.org\/10.1038\/s41598-021-89114-6","DOI":"10.1038\/s41598-021-89114-6"},{"key":"2118_CR23","doi-asserted-by":"publisher","unstructured":"Dupont J, Frau F, Robic V, et al. Beyond handcrafted radiomics in oncologic imaging: Innovations in deep, explainable, multi-site and multi-omics radiomics approaches. Diagnostic and Interventional Imaging. Published online February 13, 2026. https:\/\/doi.org\/10.1016\/j.diii.2026.02.001","DOI":"10.1016\/j.diii.2026.02.001"},{"key":"2118_CR24","doi-asserted-by":"publisher","unstructured":"Masson-Grehaigne C, Lafon M, Palussi\u00e8re J, et al. Single- and multi-site radiomics may improve overall survival prediction for patients with metastatic lung adenocarcinoma. Diagnostic and Interventional Imaging. 2024;105(11):439-452. https:\/\/doi.org\/10.1016\/j.diii.2024.07.005","DOI":"10.1016\/j.diii.2024.07.005"},{"key":"2118_CR25","doi-asserted-by":"publisher","unstructured":"Hill MO. Diversity and Evenness: A Unifying Notation and Its Consequences. Ecology. 1973;54(2):427-432. https:\/\/doi.org\/10.2307\/1934352","DOI":"10.2307\/1934352"},{"key":"2118_CR26","doi-asserted-by":"publisher","unstructured":"Moujaes E, Dupont J, Lawrance L, et al. The Role of Computed Tomography-Determined Total Tumor Volume at Baseline in Predicting Outcomes of Patients with Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma. Cancers. 2025;18(1):20. https:\/\/doi.org\/10.3390\/cancers18010020","DOI":"10.3390\/cancers18010020"},{"key":"2118_CR27","doi-asserted-by":"publisher","unstructured":"Jardali G, Lawrance L, Dawi L, et al. Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer. Diagnostic and Interventional Imaging. 2025;106(12):430-437. https:\/\/doi.org\/10.1016\/j.diii.2025.06.002","DOI":"10.1016\/j.diii.2025.06.002"},{"key":"2118_CR28","doi-asserted-by":"publisher","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). European Journal of Cancer. 2009;45(2):228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"2118_CR29","doi-asserted-by":"publisher","unstructured":"Planchard D, Popat S, Kerr K, et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2018;29:iv192-iv237. https:\/\/doi.org\/10.1093\/annonc\/mdy275","DOI":"10.1093\/annonc\/mdy275"},{"key":"2118_CR30","unstructured":"Jr G de C, Kudaba I, Wu YL, et al. Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non\u2013Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score \u2021 1% in the KEYNOTE-042 Study."},{"key":"2118_CR31","doi-asserted-by":"publisher","unstructured":"Lantuejoul S, Adam J, Girard N, et al. Tests immunohistochimiques PD-L1 dans les cancers du poumon non \u00e0 petites cellules\u202f: recommandations par le groupe PATTERN de pathologistes thoraciques. Annales de Pathologie. 2018;38(2):110-125. https:\/\/doi.org\/10.1016\/j.annpat.2018.01.007","DOI":"10.1016\/j.annpat.2018.01.007"},{"key":"2118_CR32","unstructured":"IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer. IASLC. Accessed March 5, 2026. https:\/\/www.iaslc.org\/iaslc-atlas-molecular-testing-targeted-therapy-lung-cancer"},{"key":"2118_CR33","doi-asserted-by":"publisher","unstructured":"Nioche C, Orlhac F, Boughdad S, et al. LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity. Cancer Research. 2018;78(16):4786-4789. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0125","DOI":"10.1158\/0008-5472.CAN-18-0125"},{"key":"2118_CR34","doi-asserted-by":"publisher","unstructured":"Zwanenburg A, Valli\u00e8res M, Abdalah MA, et al. The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. Radiology. 2020;295(2):328-338. https:\/\/doi.org\/10.1148\/radiol.2020191145","DOI":"10.1148\/radiol.2020191145"},{"key":"2118_CR35","doi-asserted-by":"publisher","unstructured":"Conover WJ, Iman RL. Rank Transformations as a Bridge between Parametric and Nonparametric Statistics. The American Statistician. 1981;35(3):124-129. https:\/\/doi.org\/10.1080\/00031305.1981.10479327","DOI":"10.1080\/00031305.1981.10479327"},{"key":"2118_CR36","unstructured":"Monti S, Tamayo P, Mesirov J, Golub T. Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray Data."},{"key":"2118_CR37","unstructured":"Finding Groups in Data: An Introduction to Cluster Analysis | Wiley. Accessed March 5, 2026. https:\/\/www.wiley.com\/en-us\/Finding+Groups+in+Data%3A+An+Introduction+to+Cluster+Analysis-p-9780470316801"},{"key":"2118_CR38","unstructured":"Numerical Ecology. 2012. Accessed March 5, 2026. https:\/\/shop.elsevier.com\/books\/numerical-ecology\/legendre\/978-0-444-53868-0"},{"key":"2118_CR39","unstructured":"Practical Nonparametric Statistics, 3rd Edition | Wiley. Wiley.com. Accessed March 5, 2026. https:\/\/www.wiley.com\/en-fr\/Practical+Nonparametric+Statistics%2C+3rd+Edition-p-9780471160687"},{"key":"2118_CR40","doi-asserted-by":"publisher","unstructured":"\u0218enbabao\u011flu Y, Michailidis G, Li JZ. Critical limitations of consensus clustering in class discovery. Sci Rep. 2014;4(1):6207. https:\/\/doi.org\/10.1038\/srep06207","DOI":"10.1038\/srep06207"},{"key":"2118_CR41","doi-asserted-by":"publisher","unstructured":"Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning. Springer; 2009. https:\/\/doi.org\/10.1007\/978-0-387-84858-7","DOI":"10.1007\/978-0-387-84858-7"},{"key":"2118_CR42","doi-asserted-by":"publisher","unstructured":"McInnes L, Healy J, Melville J. UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction. arXiv. Preprint posted online September 18, 2020: arXiv:1802.03426 . https:\/\/doi.org\/10.48550\/arXiv.1802.03426","DOI":"10.48550\/arXiv.1802.03426"},{"key":"2118_CR43","doi-asserted-by":"crossref","unstructured":"Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological). 1995;57(1):289-300.","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"2118_CR44","doi-asserted-by":"publisher","unstructured":"Tibshirani R. Regression Shrinkage and Selection Via the Lasso. Journal of the Royal Statistical Society Series B: Statistical Methodology. 1996;58(1):267-288. https:\/\/doi.org\/10.1111\/j.2517-6161.1996.tb02080.x","DOI":"10.1111\/j.2517-6161.1996.tb02080.x"},{"key":"2118_CR45","doi-asserted-by":"publisher","unstructured":"Graf E, Schmoor C, Sauerbrei W, Schumacher M. Assessment and comparison of prognostic classification schemes for survival data. Statist Med. 1999;18(17-18):2529-2545. https:\/\/doi.org\/10.1002\/(SICI)1097-0258(19990915\/30)18:17\/18%3C2529::AID-SIM274%3E3.0.CO;2-5","DOI":"10.1002\/(SICI)1097-0258(19990915\/30)18:17\/18%3C2529::AID-SIM274%3E3.0.CO;2-5"},{"key":"2118_CR46","doi-asserted-by":"publisher","unstructured":"Sun R, Limkin EJ, Vakalopoulou M, et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. The Lancet Oncology. 2018;19(9):1180-1191. https:\/\/doi.org\/10.1016\/S1470-2045(18)30413-3","DOI":"10.1016\/S1470-2045(18)30413-3"},{"key":"2118_CR47","doi-asserted-by":"publisher","unstructured":"Janzen I, Ho C, Melosky B, et al. Machine Learning and Computed Tomography Radiomics to Predict Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer: A Pilot Study. Cancers. 2024;17(1):58. https:\/\/doi.org\/10.3390\/cancers17010058","DOI":"10.3390\/cancers17010058"},{"key":"2118_CR48","doi-asserted-by":"publisher","unstructured":"Dercle L, Fronheiser M, Lu L, et al. Identification of Non\u2013Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics. Clinical Cancer Research. 2020;26(9):2151-2162. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2942","DOI":"10.1158\/1078-0432.CCR-19-2942"},{"key":"2118_CR49","doi-asserted-by":"publisher","unstructured":"Yadav M, Woo W, Chae YK, et al. Radiomics Models to Predict Tumor Response and Pneumonitis in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy. JCM. 2025;14(12):4330. https:\/\/doi.org\/10.3390\/jcm14124330","DOI":"10.3390\/jcm14124330"},{"key":"2118_CR50","doi-asserted-by":"publisher","unstructured":"Hartman N, Kim S, He K, Kalbfleisch JD. Pitfalls of the concordance index for survival outcomes. Statistics in Medicine. 2023;42(13):2179-2190. https:\/\/doi.org\/10.1002\/sim.9717","DOI":"10.1002\/sim.9717"},{"key":"2118_CR51","doi-asserted-by":"publisher","unstructured":"Hosny M, Elgendy IA, Ahmad Albashrawi M. Multi-Modal Deep Learning for Lung Cancer Detection Using Attention-Based Inception-ResNet. IEEE Access. 2025;13:123630-123648. https:\/\/doi.org\/10.1109\/ACCESS.2025.3588407","DOI":"10.1109\/ACCESS.2025.3588407"},{"key":"2118_CR52","doi-asserted-by":"publisher","unstructured":"He Y, Duan S, Wang W, et al. Integrative radiomics clustering analysis to decipher breast cancer heterogeneity and prognostic indicators through multiparametric MRI. npj Breast Cancer. 2024;10(1):72.https:\/\/doi.org\/10.1038\/s41523-024-00678-8","DOI":"10.1038\/s41523-024-00678-8"},{"key":"2118_CR53","doi-asserted-by":"publisher","unstructured":"Hosny M, Elgendy IA, Ahmad Albashrawi M. Beyond transfer learning: Attention-enhanced deep learning framework for multiclass gastrointestinal disease classification. Expert Systems with Applications. 2026;295:128852. https:\/\/doi.org\/10.1016\/j.eswa.2025.128852","DOI":"10.1016\/j.eswa.2025.128852"}],"container-title":["Journal of Imaging Informatics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-026-02118-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10278-026-02118-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-026-02118-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:36:31Z","timestamp":1783967791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10278-026-02118-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":53,"alternative-id":["2118"],"URL":"https:\/\/doi.org\/10.1007\/s10278-026-02118-4","relation":{},"ISSN":["2948-2933"],"issn-type":[{"value":"2948-2933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board approval was obtained (Bergoni\u00e9 Institute, Bordeaux, France).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was waived by the Institutional Review Board of Bergoni\u00e9 Institute (Bordeaux, France).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors of this manuscript declare relationships with the following companies:  Nathalie Lassau: Advisory board for Jazz Pharmaceuticals Sophie Cousin: Advisory board: Amgen, Lilly, Roche, Astrazeneca, Abbvie, BMS\u00a0Antoine Italiano: Research grant: AMGEN, AstraZeneca, Bayer, BMS Merck, MSD, Novartis, CHUGAI, Parthenon, Roche, Pharmamar, BMS dAIICHIsANKYO. Advisory board: Bayer, BMS, Merck, MSD, Novartis, CHUGAI, Parthenon, Roche, AstraZeneca, dAIICHIsANKYO. Jean Palussi\u00e8re: fees for workshop by Boston Scientific The other authors declare no financial or non-financial competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Statements and Declarations"}}]}}